Login

Financial Snapshot

Revenue
TTM
$6.826M
Gross Margin
TTM
16.48%
Net Income
TTM
-$22.99M
Current Assets
2022 Q3
Current Liabilities
2022 Q3
Current Ratio
2022 Q3
88.62%
Total Assets
2022 Q3
Total Liabilities
2022 Q3
Book Value
2022 Q3
$1.184M
Cash
2022 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$15.74M

Stock Price

Loading...
Market Cap: $1.072 Thousand

About VIVEVE MEDICAL, INC.

Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. The company is headquartered in Englewood, Colorado and currently employs 47 full-time employees. The Company’s CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Company’s wholly owned subsidiaries include Viveve, Inc. and Viveve BV.

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories ALLIED HEALTHCARE PRODUCTS INC SINTX Technologies Inc MICRON SOLUTIONS INC /DE/ Avinger Inc StimCell Enegetics Inc Motus GI Holdings, Inc. LogicMark Inc Vyome Holdings Inc Catheter Precision Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support